Squarepoint
VYGR icon

Squarepoint’s Voyager Therapeutics VYGR Stock Holding History

Squarepoint’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.1K Buy
+20,877
New +$79.2K ﹤0.01% 4240
2025
Q1 		– Sell
-38,650
Closed -$219K – 5499
2024
Q4 		$219K Sell
38,650
-32,074
-45% -$207K ﹤0.01% 4402
2024
Q3 		$414K Buy
+70,724
New +$514K ﹤0.01% 3242
2023
Q4 		– Sell
-31,181
Closed -$242K – 4560
2023
Q3 		$242K Buy
31,181
+20,506
+192% +$187K ﹤0.01% 3298
2023
Q2 		$122K Sell
10,675
-32,526
-75% -$336K ﹤0.01% 3326
2023
Q1 		$333K Buy
+43,201
New +$344K ﹤0.01% 2514
2022
Q2 		– Sell
-20,066
Closed -$153K – 3427
2022
Q1 		$153K Buy
20,066
+5,248
+35% +$23.4K ﹤0.01% 2542
2021
Q4 		$40K Sell
14,818
-18,439
-55% -$62.9K ﹤0.01% 3052
2021
Q3 		$87K Sell
33,257
-54,703
-62% -$178K ﹤0.01% 2698
2021
Q2 		$363K Buy
87,960
+73,731
+518% +$334K ﹤0.01% 2382
2021
Q1 		$67K Buy
+14,229
New +$97K ﹤0.01% 2967
2020
Q1 		– Sell
-127,179
Closed -$1.77M – 2570
2019
Q4 		$1.77M Sell
127,179
-19,591
-13% -$285K 0.01% 981
2019
Q3 		$2.53M Buy
+146,770
New +$3.08M 0.02% 755
2019
Q1 		– Sell
-34,983
Closed -$329K – 2462
2018
Q4 		$329K Buy
34,983
+19,883
+132% +$255K ﹤0.01% 1460
2018
Q3 		$286K Sell
15,100
-3,700
-20% -$71K ﹤0.01% 1564
2018
Q2 		$367K Buy
+18,800
New +$372K ﹤0.01% 1302
2018
Q1 		– Sell
-13,768
Closed -$229K – 2186
2017
Q4 		$229K Buy
+13,768
New +$236K ﹤0.01% 1720

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Squarepoint's VYGR Position: Q2 2026 in Review

Squarepoint opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 20,877 shares worth $73.1K. The stake represents ﹤0.01% of the portfolio and ranks #4240 among its holdings. This is a return to the name: Squarepoint previously reported a position in VYGR as recently as Q4 2024.

Squarepoint first reported a position in VYGR in Q4 2017 and has held it in 17 quarters since. The position peaked at $2.53M in Q3 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Squarepoint held 20,877 shares of Voyager Therapeutics worth $73.1K as of Q2 2026.
  • Voyager Therapeutics was a new Squarepoint position in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4240 holding.
  • Squarepoint first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 17 quarters since.
  • Squarepoint's Voyager Therapeutics position peaked at $2.53M in Q3 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.